Targeting the liver with nucleic acid therapeutics for the treatment of systemic diseases of liver origin

A Gogate, J Belcourt, M Shah, AZ Wang… - Pharmacological …, 2024 - Elsevier
Systemic diseases of liver origin (SDLO) are complex diseases in multiple organ systems,
such as cardiovascular, musculoskeletal, endocrine, renal, respiratory, and sensory organ …

Enhancing the effectiveness of oligonucleotide therapeutics using cell-penetrating peptide conjugation, chemical modification, and carrier-based delivery strategies

S Anwar, F Mir, T Yokota - Pharmaceutics, 2023 - mdpi.com
Oligonucleotide-based therapies are a promising approach for treating a wide range of hard-
to-treat diseases, particularly genetic and rare diseases. These therapies involve the use of …

High-throughput chromatographic separation of oligonucleotides: a proof of concept using ultra-short columns

H Lardeux, S Fekete, M Lauber, V D'Atri… - Analytical …, 2023 - ACS Publications
Ion-pairing reversed-phase liquid chromatography (IP-RPLC) is the reference separation
technique for characterizing oligonucleotides (ONs) and their related impurities. The aim of …

Long noncoding RNA Regulating ImMune Escape regulates mixed lineage leukaemia protein‐1‐H3K4me3‐mediated immune escape in oesophageal squamous …

J Liu, WY Zhou, XJ Luo, YX Chen… - Clinical and …, 2023 - Wiley Online Library
Background Predictive biomarkers for oesophageal squamous cell carcinoma (ESCC)
immunotherapy are lacking, and immunotherapy resistance remains to be addressed. The …

mRNA delivery enabled by metal–organic nanoparticles

Y Gu, J Chen, Z Wang, C Liu, T Wang, CJ Kim… - Nature …, 2024 - nature.com
Abstract mRNA therapeutics are set to revolutionize disease prevention and treatment,
inspiring the development of platforms for safe and effective mRNA delivery. However …

Splice modulation strategy applied to deep intronic variants in COL7A1 causing recessive dystrophic epidermolysis bullosa

N Pironon, E Bourrat, C Prost, M Chen… - Proceedings of the …, 2024 - pnas.org
Recessive dystrophic epidermolysis bullosa (RDEB) is a rare and most often severe genetic
disease characterized by recurrent blistering and erosions of the skin and mucous …

Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide

US Haque, T Yokota - Cells, 2023 - mdpi.com
Antisense oligonucleotide-based (ASO) therapeutics have emerged as a promising strategy
for the treatment of human disorders. Charge-neutral PMOs have promising biological and …

[HTML][HTML] Control of cell penetration enhancer shielding and endosomal escape-kinetics crucial for efficient and biocompatible siRNA delivery

A Malfanti, H Sami, A Balasso, G Marostica… - Journal of Controlled …, 2023 - Elsevier
Although cationic liposomes are efficient carriers for nucleic acid delivery, their toxicity often
hampers the clinical translation. Polyethylene glycol (PEG) coating has been largely used to …

Improvement of serum sample preparation and chromatographic analysis of nusinersen used for the treatment of spinal muscular atrophy

S Studzińska, J Szymarek, M Mazurkiewicz-Bełdzińska - Talanta, 2024 - Elsevier
The present investigation showed that each of the three different liquid chromatography
modes may be successfully used for the qualitative analysis of nusinersen metabolites in a …

Scientific review of the proarrhythmic risks of oligonucleotide therapeutics: are dedicated ICH S7B/E14 studies needed for low‐risk modalities?

Y Qu, KA Henderson, TA Harper Jr… - Clinical Pharmacology …, 2024 - Wiley Online Library
Oligonucleotide therapeutics (ONTs) represent a new modality with unique pharmacological
and chemical properties that modulate gene expression with a high degree of target …